We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Stay Ahead of the Game With VAREX IMAGING (VREX) Q3 Earnings: Wall Street's Insights on Key Metrics
Read MoreHide Full Article
In its upcoming report, VAREX IMAGING (VREX - Free Report) is predicted by Wall Street analysts to post quarterly earnings of $0.22 per share, reflecting an increase of 22.2% compared to the same period last year. Revenues are forecasted to be $216.57 million, representing a year-over-year increase of 6.7%.
Over the past 30 days, the consensus EPS estimate for the quarter has remained unchanged. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.
Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.
While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights.
With that in mind, let's delve into the average projections of some VAREX IMAGING metrics that are commonly tracked and projected by analysts on Wall Street.
It is projected by analysts that the 'Revenues- Industrial' will reach $63.39 million. The estimate indicates a year-over-year change of +4.1%.
The collective assessment of analysts points to an estimated 'Revenues- Medical' of $153.02 million. The estimate indicates a change of +7.7% from the prior-year quarter.
Based on the collective assessment of analysts, 'Gross profit- Industrial' should arrive at $22.78 million. The estimate compares to the year-ago value of $20.80 million.
The consensus among analysts is that 'Gross profit- Medical' will reach $49.56 million. The estimate is in contrast to the year-ago figure of $46.70 million.
Shares of VAREX IMAGING have experienced a change of +15.2% in the past month compared to the +3.3% move of the Zacks S&P 500 composite. With a Zacks Rank #3 (Hold), VREX is expected to mirror the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
View the Zacks #1 Rank List
Image: Bigstock
Stay Ahead of the Game With VAREX IMAGING (VREX) Q3 Earnings: Wall Street's Insights on Key Metrics
In its upcoming report, VAREX IMAGING (VREX - Free Report) is predicted by Wall Street analysts to post quarterly earnings of $0.22 per share, reflecting an increase of 22.2% compared to the same period last year. Revenues are forecasted to be $216.57 million, representing a year-over-year increase of 6.7%.
Over the past 30 days, the consensus EPS estimate for the quarter has remained unchanged. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.
Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.
While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights.
With that in mind, let's delve into the average projections of some VAREX IMAGING metrics that are commonly tracked and projected by analysts on Wall Street.
It is projected by analysts that the 'Revenues- Industrial' will reach $63.39 million. The estimate indicates a year-over-year change of +4.1%.
The collective assessment of analysts points to an estimated 'Revenues- Medical' of $153.02 million. The estimate indicates a change of +7.7% from the prior-year quarter.
Based on the collective assessment of analysts, 'Gross profit- Industrial' should arrive at $22.78 million. The estimate compares to the year-ago value of $20.80 million.
The consensus among analysts is that 'Gross profit- Medical' will reach $49.56 million. The estimate is in contrast to the year-ago figure of $46.70 million.
View all Key Company Metrics for VAREX IMAGING here>>>Shares of VAREX IMAGING have experienced a change of +15.2% in the past month compared to the +3.3% move of the Zacks S&P 500 composite. With a Zacks Rank #3 (Hold), VREX is expected to mirror the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .